BACKGROUND: @entity490 ( @entity490 ) is one of the most common diseases, and large percentages of @entity1 suffer from it. OBJECTIVES: The purpose of the study was to evaluate the effect of @entity6374 in treatment of @entity1 with functional @entity490 . @entity1 AND METHODS: This study was a randomized double-blind placebo-controlled trial. @entity1 aged 4 to 16 years with chronic functional @entity490 (based on Rome III criteria) were enrolled in the study. They were randomly divided into two groups, one receiving probiotic and the other placebo. RESULTS: Forty @entity1 received probiotic and forty others placebo. There were no significant differences in age, weight, sex, location of @entity158 , associated symptoms, frequency and intensity of @entity158 between the groups. The severity and frequency of @entity490 in the first month compared to baseline was significantly less and at the end of the second month, there was no significant difference between both groups compared to the end of the first month. CONCLUSIONS: This study showed that the severity of @entity158 was significantly reduced in both groups. There was no significant difference in @entity158 scores between them. The effect of probiotic and placebo can probably be attributed to psychological effect of the drugs.

A Randomized Double-Blind Placebo-Controlled Trial of XXXX for Chronic Functional Abdominal Pain in @entity1 .

@entity1 :: ('9606', 'Species') :: ['children', 'Children', 'PATIENTS'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain'] @entity490 :: ('MESH:D015746', 'Disease') :: ['FAP', 'abdominal pain', 'Functional abdominal pain'] @entity6374 :: ('1598', 'Species') :: ['Lactobacillus reuteri']
@entity6374 :: (1598,Species) :: ['Lactobacillus reuteri']
